VIVEX Biologics introduced the VIAGENEX™ family of amniotic allografts, processed to retain the mechanical properties of amniotic tissue and rich supply of extracellular matrix, growth factors and cytokines.
VIAGENEX offers a soft tissue barrier and wound covering in clinical settings such as shoulder, nerve, knee and tendon repair. The larger-sized amniotic allografts can also be used as a mechanical barrier in surgical applications, including spine and neurosurgery.
VIAGENEX is available in two forms to support clinical applications, both hydrating rapidly in place and with a 5-year shelf life:
VIAGENEX Matrix is an intact amniotic membrane at 400-500µm, with the full amnion, chorion, and intermediate spongy layer preserved.
VIAGENEX Max umbilical cord membrane is the thickest amniotic membrane available at 800-1,000µm and is robust enough to be sutured in place.
“The launch of VIAGENEX directly supports VIVEX’s mission to improve patient care through the innovation of tissue and biologics-based therapies that are designed to support the healing and regenerative potential of the body,” said Gail Farnan, General Manager of Amnion and Wound Care Therapies at VIVEX.
VIVEX Biologics introduced the VIAGENEX™ family of amniotic allografts, processed to retain the mechanical properties of amniotic tissue and rich supply of extracellular matrix, growth factors and cytokines.
VIAGENEX offers a soft tissue barrier and wound covering in clinical settings such as shoulder, nerve, knee and tendon repair. The...
VIVEX Biologics introduced the VIAGENEX™ family of amniotic allografts, processed to retain the mechanical properties of amniotic tissue and rich supply of extracellular matrix, growth factors and cytokines.
VIAGENEX offers a soft tissue barrier and wound covering in clinical settings such as shoulder, nerve, knee and tendon repair. The larger-sized amniotic allografts can also be used as a mechanical barrier in surgical applications, including spine and neurosurgery.
VIAGENEX is available in two forms to support clinical applications, both hydrating rapidly in place and with a 5-year shelf life:
VIAGENEX Matrix is an intact amniotic membrane at 400-500µm, with the full amnion, chorion, and intermediate spongy layer preserved.
VIAGENEX Max umbilical cord membrane is the thickest amniotic membrane available at 800-1,000µm and is robust enough to be sutured in place.
“The launch of VIAGENEX directly supports VIVEX’s mission to improve patient care through the innovation of tissue and biologics-based therapies that are designed to support the healing and regenerative potential of the body,” said Gail Farnan, General Manager of Amnion and Wound Care Therapies at VIVEX.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
